The personalized fertility care market is projected to grow from USD 1.3 billion in 2026 to USD 3.7 billion by 2036, at a CAGR of 11.0%. Diagnostics & genomics will dominate with a 40.0% market share, while conception assistance will lead the application segment with a 50.0% share.